AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and Related Disorders
AZ@GAME-Eco
1 other identifier
interventional
136
1 country
1
Brief Summary
The main objective of AZ@GAME ECO is to evaluate the cost-utility of the management of patients suffering from Alzheimer's disease using a serious game providing cognitive and physical straining compared to a usual management. Among the secondary objectives it is important to assess the real life feasibility in different types of care structures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable alzheimer-disease
Started Sep 2017
Longer than P75 for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2017
CompletedFirst Posted
Study publicly available on registry
July 5, 2017
CompletedStudy Start
First participant enrolled
September 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
ExpectedJune 15, 2026
June 1, 2026
6 months
June 26, 2017
June 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
cost utility ratio
Measurement of the incremental cost-utility ratio of the management of patients suffering from Alzheimer's disease
at 3 months
Study Arms (2)
serious games
EXPERIMENTALusual care
ACTIVE COMPARATORInterventions
This program has enabled several SGs to be developed that allow physical and cognitive workouts to be carried out with a therapist
Eligibility Criteria
You may qualify if:
- Male or Female ≥ 60 years of age;
- Subjects diagnosed with Alzheimer's Disease or related disorders associated with mild to moderately severe (CIM 10)
- a score between 12 and 24 on the Mini Mental score evaluation
- Subject treated in one of the participating centers
- To have the social welfare insurance
- Signature of the free and informed consent in the case of a patient under guardianship with signature of the guardian
You may not qualify if:
- history of epilepsy
- major walking or balance disorder.
- Subject without freedom by judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice
Nice, France
Related Publications (1)
Robert P, Albrengues C, Fabre R, Derreumaux A, Pancrazi MP, Luporsi I, Dubois B, Epelbaum S, Mercier G, Foulon P, Bremond F, Manera V. Efficacy of serious exergames in improving neuropsychiatric symptoms in neurocognitive disorders: Results of the X-TORP cluster randomized trial. Alzheimers Dement (N Y). 2021 May 11;7(1):e12149. doi: 10.1002/trc2.12149. eCollection 2021.
PMID: 34013018BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2017
First Posted
July 5, 2017
Study Start
September 30, 2017
Primary Completion
March 30, 2018
Study Completion (Estimated)
December 30, 2027
Last Updated
June 15, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share